Feature image credits: Memorial Sloan Kettering Cancer Center
It was a life-changing day for 12 patients living in the United States when they found that their cancer had vanished, thanks to a small clinical trial. Of the total number of patients, these were the patients who completed the trial.
The New York Times reported that a drug named Dostarlimab was administered to these patients — all suffering from rectal cancer — over six months. All 12 patients entered remission after the period.
Comments are closed.